DermTech Dermtech Q3 Revenues Rise 122 Percent The company said it recorded a 75 percent increase in billable sample volume during the quarter, and a 140 percent increase in assay revenues. DermTech Revenues Nearly Quadruple in Q2 The company attributed the revenue spike to higher billable sample volume and improved average selling price for its skin cancer assays. DermTech Q1 Revenues up 62 Percent The firm processed approximately 9,400 billable samples in Q1, a 62 percent increase compared to approximately 5,800 samples in Q1 of 2020. BTIG Initiates Coverage of DermTech With Buy Rating The investment bank said DermTech's pigmented lesion assay for the early detection of melanoma is well positioned in an estimated $3 billion-plus market. DermTech Partners With Stanford School of Medicine to Study Chronic Skin Disorder The partners will use DermTech's genomics technologies to identify biomarkers of hidradenitis suppurativa, a chronic and painful skin condition. Mar 5, 2021 DermTech Q4 Revenues Up 31 Percent Feb 12, 2021 DermTech Enters Agreement With Blue Cross Blue Shield of Texas for Skin Cancer Assay Jan 28, 2021 DermTech Using $144M Financing to Spur Marketing, Telemedicine Efforts For Molecular Melanoma Assay Premium Jan 22, 2021 Oppenheimer Initiates Coverage of DermTech With Outperform Rating Jan 7, 2021 DermTech Prices $125M Public Offering of Common Stock Dec 14, 2020 Craig-Hallum Initiates Coverage of DermTech With Buy Rating Sep 11, 2020 People in the News: New Appointments at CareDx, Sherlock Biosciences, DermTech, More Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.